ArticlePharmaceutical research2019

New Insights into Using Lipid Based Suspensions for 'Brick Dust' Molecules: Case Study of Nilotinib.

Niklas J Koehl et al.PubMed ↗Publisher ↗

No numbers read from the abstract.